Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Pharnext (France)
h-index: 19
Total citations: 2,225
Total papers: 51
Homepage:
https://pharnext.com/
Recent papers from Pharnext (France)
Identifying Minimum Threshold Level of Trial Crossover Rates Yielding Nonsignificant Overall Survival Benefit Associated with Cancer Treatments: A Systematic Literature Review of HTA Submissions
Journal of health economics and outcomes research · 2026
Patient-Reported Symptom Burden of Charcot–Marie–Tooth Disease Type 1A: Findings From an Observational Digital Lifestyle Study
Journal of Clinical Neuromuscular Disease · 2022
Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer’s Disease
Journal of Alzheimer s Disease · 2022
An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy‐induced peripheral neuropathy, based on preclinical studies in rodent models
Fundamental and Clinical Pharmacology · 2020
Patient-reported Impact of Charcot-Marie-Tooth Disease: Protocol for a real-world Digital Lifestyle Study
Neurodegenerative Disease Management · 2020
Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis
Journal of Neuroscience Research · 2020
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats
Journal of Neuroscience Research · 2020
Focusing on the Unfolded Protein Response and Autophagy Related Pathways to Reposition Common Approved Drugs against COVID-19
2020
Next-generation drug repurposing using human genetics and network biology
Current Opinion in Pharmacology · 2020
Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection
Vaccine · 2019
Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab
Scientific Reports · 2019
Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents
JAMA Psychiatry · 2019
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)
PLoS ONE · 2019
Enabling STD-NMR fragment screening using stabilized native GPCR: A case study of adenosine receptor
Scientific Reports · 2018
Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder
Journal of Neuropathology & Experimental Neurology · 2018
Molecular architecture of potassium chloride co-transporter KCC2
Scientific Reports · 2017
[P3–047]: A COMBINATION OF ACAMPROSATE AND BACLOFEN (PXT864) SYNERGIZES WITH STANDARDS OF CARE FOR THE TREATMENT OF ALZHEIMER's DISEASE
Alzheimer s & Dementia · 2017
NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration
Neurobiology of Disease · 2017
Molecular changes in the postmortem parkinsonian brain
Journal of Neurochemistry · 2016
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease
Scientific Reports · 2015